We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

475 hedge funds and large institutions have $9.94B invested in United Therapeutics in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 192 increasing their positions, 161 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more call options, than puts

Call options by funds: $22.4M | Put options by funds: $17.2M

19% more repeat investments, than reductions

Existing positions increased: 192 | Existing positions reduced: 161

2% less capital invested

Capital invested by funds: $10.1B → $9.94B (-$195M)

2.48% less ownership

Funds ownership: 98.65% → 96.18% (-2.5%)

6% less funds holding

Funds holding: 506 → 475 (-31)

18% less funds holding in top 10

Funds holding in top 10: 17 → 14 (-3)

39% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 74

Holders
475
Holders Change
-31
Holders Change %
-6.13%
% of All Funds
7.46%
Holding in Top 10
14
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-17.65%
% of All Funds
0.22%
New
45
Increased
192
Reduced
161
Closed
74
Calls
$22.4M
Puts
$17.2M
Net Calls
+$5.14M
Net Calls Change
+$7.57M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$201M
2
O
OrbiMed
New York
+$89M
3
BlackRock
BlackRock
New York
+$76.4M
4
ITP
Iron Triangle Partners
Connecticut
+$44.3M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$30.4M

Top Sellers

1
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$107M
2
FCM
Farallon Capital Management
California
-$104M
3
PCH
Polar Capital Holdings
United Kingdom
-$72.6M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$44.4M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$39.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Truist Financial
226
Truist Financial
North Carolina
$1.42M +$293K +1,322 +26%
Los Angeles Capital Management
227
Los Angeles Capital Management
California
$1.42M -$22M -99,413 -94%
NERM
228
New England Research & Management
Illinois
$1.39M +$158K +715 +13%
Public Employees Retirement Association of Colorado
229
Public Employees Retirement Association of Colorado
Colorado
$1.34M -$10.6K -48 -0.8%
HW
230
Hancock Whitney
Mississippi
$1.33M -$1.17M -5,299 -47%
EA
231
Emerald Advisers
Pennsylvania
$1.32M -$16M -72,089 -92%
AG
232
Algert Global
California
$1.31M +$88.6K +400 +7%
ProShare Advisors
233
ProShare Advisors
Maryland
$1.27M -$33.7K -152 -3%
EGM
234
Engineers Gate Manager
New York
$1.27M +$135K +608 +12%
X
235
Xponance
Pennsylvania
$1.26M -$90.2K -407 -7%
NIM
236
Nicollet Investment Management
Minnesota
$1.25M +$29.5K +133 +2%
MFG
237
MidWestOne Financial Group
Iowa
$1.24M -$93.5K -422 -7%
LPL Financial
238
LPL Financial
California
$1.22M -$77.5K -350 -6%
TRCT
239
Tower Research Capital (TRC)
New York
$1.21M +$807K +3,644 +198%
N
240
Natixis
France
$1.19M +$1.16M +5,223 +3,244%
NAM
241
NorthCrest Asset Manangement
Minnesota
$1.18M – – –
Stifel Financial
242
Stifel Financial
Missouri
$1.17M -$105K -472 -8%
PRC
243
Pearl River Capital
Michigan
$1.16M -$540K -2,437 -32%
Commonwealth Equity Services
244
Commonwealth Equity Services
Massachusetts
$1.16M -$28.8K -130 -2%
CIC
245
Cornercap Investment Counsel
Georgia
$1.15M – – –
IMCOOI
246
Investment Management Corp of Ontario (IMCO)
Canada
$1.14M +$1.14M +5,158 New
CAM
247
Cresset Asset Management
Illinois
$1.12M +$1.12M +5,054 New
Korea Investment Corp
248
Korea Investment Corp
South Korea
$1.11M -$1.54M -6,965 -58%
KWMG
249
King Wealth Management Group
Florida
$1.1M – – –
NAM
250
Nissay Asset Management
Japan
$1.08M +$47.2K +213 +5%
8 9
10
11 12

UTHR Hedge Fund Activity: Q2 2023 in Review

475 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2023, worth a combined $9.94B — down 1.9% from $10.1B a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of UTHR and 45 opened new positions — a net loss of 29 holders — while 161 trimmed existing stakes and 192 added.

The largest buyer was Wellington Management Group, adding an estimated $201M. The largest seller was Envestnet Asset Management, cutting an estimated $107M.

  • 475 institutional investors held United Therapeutics (UTHR) as of Q2 2023, down from 506 in Q1 2023.
  • Funds reported $9.94B of United Therapeutics stock for Q2 2023, down 1.9% quarter-over-quarter.
  • 45 funds opened new United Therapeutics positions in Q2 2023 and 74 closed out, a net change of -29 holders.
  • The largest United Therapeutics buyer in Q2 2023 was Wellington Management Group, an estimated $201M added.
  • The largest United Therapeutics seller in Q2 2023 was Envestnet Asset Management, an estimated $107M sold.

Based on aggregated 13F filings for Q2 2023.